A study to compare CTLA-4 levels on tumor cells with those on tumor infiltrating lymphocytes and correlated them with clinical response to Ipilimumab
Latest Information Update: 15 Mar 2021
At a glance
- Drugs Ipilimumab (Primary)
- Indications Bone metastases; Cancer metastases; Liver metastases; Malignant melanoma; Skin cancer
- Focus Pharmacodynamics; Therapeutic Use
- 15 Mar 2021 New trial record